News

Findings show statin use tied to higher HbA1c values, with longer statin use tied to greater risk for diabetes

Greater organ-absorbed doses may be modestly positively associated with risk of solid cancer death

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for June 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.Medtronic Recalls …

Survival benefit not seen with ever use of metformin for pancreatic cancer-related diabetes

Lower values for resorption end points at month two persisted to month 12, indicating reduced turnover

Increasing magnitude of stress myocardial perfusion abnormality tied to cardiac death risk in diabetes

Prevalence of high caregiver burden increased after initiation of dialysis

The company and FDA say certain pumps are vulnerable to hacking

Event rates did not differ for atrial fibrillation, myocardial infarction, congestive heart failure, stroke

Risk down particularly when linoleic acids replace saturated fats, trans fats, or carbohydrates